Safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive advanced breast cancer: Primary results from the KAMILLA study cohort 1-Reference-Cited by-同舟云学术

Safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive advanced breast cancer: Primary results from the KAMILLA study cohort 1

Published:2019-03 Issue: Volume:109 Page:92-102
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Montemurro Filippo^ORCID,Ellis Paul,Anton Antonio,Wuerstlein Rachel,Delaloge Suzette,Bonneterre Jacques,Quenel-Tueux Nathalie,Linn Sabine C.,Irahara Natsumi,Donica Margarita,Lindegger Nicolas,Barrios Carlos H.

Funder

F. Hoffmann–La Roche, Ltd.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference15 articles.

1. KADCYLA® (ado-trastuzumab emtansine) for injection [package insert],2016

2. KADCYLA® (ado-trastuzumab emtansine) [Summary of product characteristics],2017

3. NCCN clinical practice guidelines in oncology: breast cancer version 2;National Comprehensive Cancer Network,2017

4. Trastuzumab emtansine for HER2-positive advanced breast cancer;Verma;N Engl J Med,2012

5. Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomized, open-label, phase 3 trial;Krop;Lancet Oncol,2014

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical best practices in interdisciplinary management of human epidermal growth factor receptor 2 antibody‐drug conjugates–induced interstitial lung disease/pneumonitis: An expert consensus in China;Cancer;2024-08-02

2. Depicting Biomarkers for HER2-Inhibitor Resistance: Implication for Therapy in HER2-Positive Breast Cancer;Cancers;2024-07-24

3. Gastrointestinal Toxicity of Antibody Drug Conjugates (ADCs) in Metastatic Breast Cancer: A Pooled Analysis;Clinical Breast Cancer;2024-07

4. Local delivery of accutox® synergises with immune-checkpoint inhibitors at disrupting tumor growth;Journal of Translational Medicine;2024-06-03

5. Decrypting the multi-genome data for chimeric vaccine designing against the antibiotic resistant Yersinia pestis;International Immunopharmacology;2024-05